Top Federal Drug Official Praises Psychedelics’ Potential, Psilocybin And Ketamine On City Health Plans And More
“Tremendous Excitement” Around Psychedelic Medicine, Says Top Federal Drug Official
There is “tremendous excitement” about the therapeutic potential of psychedelics, says National Institute on Drug Abuse (NIDA) Director Nora Volkow. However, this top federal drug official emphasized that while promising, psychedelic treatments need more rigorous research and are “not magic.”
During a Senate Appropriations Subcommittee hearing, Volkow explained that despite growing enthusiasm, current data does not fully support widespread use, reported Marijuana Moment. Sen. Brian Schatz (D-HI) inquired about current research status, stressing the need for evidence from agencies like NIDA before calling certain substances medicine. Meanwhile, Volkow stressed the importance of understanding optimal administration to ensure long-term benefits and minimize risks, underscoring the need for further studies.
Join industry leaders and pioneering experts as we explore the future of alternative mental health treatments at the …